Øget CPK, myalgi, myositis og sjældent rhabdomyolyse er rapporteret med proteasehæmmere, særligt i kombination med nukleosidanaloger.
Increased CPK, myalgia, myositis, and rarely rhabdomyolysis have been reported with protease inhibitors, particularly in combination with nucleoside analogues.